Question · asked by 1 review
NSAIDs vs placebo: Participant‐reported pain relief of 30% or greater
- Population
- adults with sickle cell disease in a vaso‐occlusive crisis
- Intervention
- NSAIDs
- Comparison
- placebo
- Outcome
- Participant‐reported pain relief of 30% or greater
The review found no eligible studies for this question.
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Non‐steroidal anti‐inflammatory drugs (NSAID) vs placebo Participant‐reported pain relief of 30% or greater · adults with sickle cell disease in a vaso‐occlusive crises The review found no eligible studies for this question. Pharmacological interventions for painful sickle cell vaso‐occlusive crises in adults (2019) · Cochrane Headline outcomes only | no estimate extracted | Not reported | No studies found |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Pharmacological interventions for painful sickle cell vaso‐occlusive crises in adults 2019 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.